Tuba Reçber

Tuba Reçber

Auto-generated profile, based on publicly available information

Tuba Reçber

Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Sıhhiye, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Advanced Biology
Verified
Journal Article
Closed access
GKGamze Koçak
Gamze Koçak
SUSude Uyulgan
Sude Uyulgan
EPElifsu Polatlı
Elifsu Polatlı
VSVedat Sarı
Vedat Sarı
BKBurak Kahveci
Burak Kahveci
SGSinan Güven
Sinan Güven

8 April 2020 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
TRTuba Recber
Tuba Recber
GOGokcen Orgul
Gokcen Orgul
EAEmine Aydın
Emine Aydın
ATAtakan Tanaçan
Atakan Tanaçan
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
MBMehmet Sinan Beksac
Mehmet Sinan Beksac

28 December 2020 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
ARAmal Rebai
Amal Rebai
TRTuba Reçber
Tuba Reçber
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
CCChahra Chbili
Chahra Chbili
SEVINC KURBANOGLUSEVINC KURBANOGLU
SEVINC KURBANOGLU
SSSaad Saguem
Saad Saguem
Aim and Objective: Parkinson’s disease (PD) is the second most common neurodegenerative disease. It is a multifactorial disorder (caused by aging, environmental, and genetic factors). Metabolomics can help explore the biomarker profiles for aging. Recent studies showed an association between the glutathione S-transferases (GSTs) polymorphisms and PD risk. The purpose of this study was to evaluate the association of this genetic polymorphism and the metabolomic profile in PD Tunisian patients, in order to identify effective biomarkers in the genetic differentiation. Materials and Methods: In this study, the metabolomic profile changes related to GSTs polymorphism were searched in 54 Tunisian PD patients treated with L-dopa, using a gas chromatography-mass spectrometry (GC-MS) technique. Results: The study results showed that mannose, methyl stearate, and three other unknown metabolites, increased in patients with GSTM1 positive genotype, while glycolic acid, porphine, monomethyl phosphate, fumaric acid, and three other unknown metabolites decreased in patients with GSTM1 positive genotype. Subsequently, the levels of glycolic acid, erythronic acid, lactic acid, citric acid, fructose, stearic acid, 2-amino-2-methyl-1,3-propanediol and three other unknown metabolites increased in patients with GSTM1 positive genotype, while the levels of proline, valine and two unknown metabolites decreased with GSTT1 positive genotype. Conclusion: All these altered metabolites are related to energy metabolism and it can be concluded that GSTs polymorphism based the shifting in energy metabolism and led to oxidative stress.

3 October 2024 in International Journal of Food Sciences and Nutrition
Verified
Journal Article
Closed access
IAİsmail Mücahit Alptekin
İsmail Mücahit Alptekin
FÇFunda Pınar Çakıroğlu
Funda Pınar Çakıroğlu
TRTuba Reçber
Tuba Reçber
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
High-fat diets contribute to various metabolic disorders. Inulin supplementation has been shown to reduce appetite, lower food intake, and promote weight loss. Although there is evidence that the endocannabinoid system has metabolic effects in the prefrontal cortex, studies investigating the effects of inulin on the endocannabinoid system are limited. This study investigated the impact of inulin on obesity through the endocannabinoid system in the prefrontal cortex. Twenty-four male Wistar rats were fed one of four diets over 12 weeks. Findings indicated that a high-fat diet led to obesity, whereas inulin reduced food intake and supported weight loss. Consequently, inulin supplementation both prevented obesity and significantly decreased the expressions of Adrb3 and Adcy1, and anandamide and 2-arachidonylglycerol levels in the prefrontal cortex. Additionally, inulin lowered leptin in circulation and stimulated Trpv1. Thus, inulin may mitigate obesity development, possibly by modulating gene expressions linked to obesity in the prefrontal cortex via endocannabinoids.

2 July 2025 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ÖTözlem tezol
özlem tezol
SYSıddika Songül Yalçın
Sıddika Songül Yalçın
TRTuba Reçber
Tuba Reçber
AYAnıl Yirün
Anıl Yirün
AÖAylin Balcı Özyurt
Aylin Balcı Özyurt
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
Spasticity, pain, fatigue and other secondary consequences of spastic CP may lead to metabolic alterations. The aim of this study was to analyze the plasma metabolomic profiles of children with spastic CP and compare these with typically developing controls. This case–control study (n = 50 for CP and n = 55 for control) was conducted between September 2020 and November 2020 at Mersin University Hospital. Three to ten year old patients with spastic CP and age- and sex-matched typically developing controls were included in the study. Data on anthropometric measurements and clinical profiles were collected. Plasma samples were obtained for non-targeted metabolomics. The GC–MS based metabolomics analysis was performed. Metaboanalyst software was used for multivariate analyses, principal component analysis and pathway analyses. Spastic quadriplegia, spastic diplegia and spastic hemiplegia were found in 26 (52%), 14 (28%) and 10 (20%) patients, respectively, and 31 patients (62%) were non-ambulant. Twenty-two patients (44%) had epilepsy and antiepileptic use. Mean weight-for-age, height-for- age, and body mass index z-scores were significantly lower in the CP group (p < 0.05). Total 224 metabolites were detected in all subjects. Of these metabolites, 14 were detected at higher and 37 at lower levels in the CP group compared to the control group. The most significant changes in the CP group were found in aminoacyl-tRNA biosynthesis, tyrosine metabolism, valine, leucine and isoleucine biosynthesis, alanine, aspartate and glutamate metabolism, arginine and proline metabolism, citrate cycle (TCA cycle), galactose metabolism and glutathione metabolism. Forty-five metabolites were statistically significant between control, CP with epilepsy and CP without epilepsy groups. Thirty-four metabolites were statistically significant between control, ambulant CP and non-ambulant CP groups. Plasma of spastic CP children was associated with alterations in energy metabolism and protein synthesis and amino acid metabolism compared to typically developing children. Gross motor functional level and accompanying epilepsy may also alter the metabolite profiles.

8 March 2021 in Bioanalysis
Verified
Journal Article
Closed access
NENAZLI ERDOĞAR
NAZLI ERDOĞAR
TRTuba Reçber
Tuba Reçber
AIAlper B İsKit
Alper B İsKit
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
SKSedef Kır
Sedef Kır
Emirhan NemutluEmirhan Nemutlu
Emirhan Nemutlu
Aim: The assessment of efficacy should be paralleled with extensive pharmacokinetic parameters, and a valid bioanalytical method is a pre-condition for accurate plasma concentration. Materials & me...